Chris Chen
Chris Chen is the CEO of WuXi Biologics. Dr Chen served on the International Board of Directors for ISPE and holds a PhD in Chemical Engineering from the University of Delaware.
Articles
Latest Updated Articles
Published: October 11th 2024 | Updated: March 3rd 2025
Exploring New Advancements in ADC Technologies (CPHI Milan 2024)
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: July 4th 2025 | Updated: August 6th 2025
Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics
Published: July 25th 2025 | Updated: August 6th 2025
ICH Q12 and Post-Approval Changes–Less than Satisfactory State of Affairs
Published: July 21st 2025 | Updated: August 6th 2025
Video Interview With Chris Hagen, President of SCIEX
